Data as of Apr 17
 -0.01 / -0.30%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Ziopharm Oncology, Inc. is a biopharmaceutical company, which is engaged in the development and commercialization of in-licensed cancer drugs that can address unmet medical needs. It focuses on the licensing and development of proprietary small molecule drug candidates that are related to cancer therapeutics already on the market or in development and that can be administered by intravenous and oral dosing. The company is currently focused on three clinical programs: Zymafos, Zybulin and Zinapar. Ziopharm Oncology was founded on September 9, 2003 and is headquartered in New York, NY.

Contact Information

ZIOPHARM Oncology, Inc.
1180 Avenue of the Americas
New York New York 10036
P:(646) 214-0700
Investor Relations:



Individual stakeholders32.87%
Mutual fund holders19.77%
Other institutional15.36%

Top Executives

Jonathan J. LewisChief Executive Officer & Director
Kevin G. LafondCFO, Treasurer, CAO, Corporate Controller & VP
Robert MorganSenior Vice President-Regulatory Affairs & Quality
Tyler CookSVP-Finance, Administration & Information Systems
Robert NewmanSenior VP-Clinical Operations & Manufacturing

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.